Bougie Diameter on Outcomes in Laparoscopic Sleeve Gastrectomy

Recruiting N/A Interventional Study
Bariatric Sleeve Gastrectomy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
100 (estimated)
Sponsor
General Committee of Teaching Hospitals and Institutes, Egypt · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Laparoscopic sleeve gastrectomy (LSG) has become an increasingly popular bariatric procedure since its first performance by Hess and Hess in 1988 as a component of the biliopancreatic diversion-duodenal switch (BPD-DS) procedure, which was modified from Scopinaro's biliopancreatic diversion (BPD) and DeMeester's technique. In the early part of the twenty-first century, it was popularized as a firs…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Adult patients aged between 18 and 70 years undergoing LSG as a primary bariatric procedure 2. Body mass index (BMI) criteria according to 2022 ASMBS/IFSO guidelines: * BMI ≥35 kg/m² regardless of presence, absence, or severity of comorbidities, OR * BMI 30-34.9 kg/m² …
Contacts

Mohamed Ashour, PhD

00201002600970

dr.mhany@gmail.com

CONTACT